Orchid Pharma rises from ashes, expects to make profits in 12 months
24 Mar 2021 //
BUSINESS-STANDARD
Orchid Hlthcare’S Generic Zolmitriptan Receives Approval In US
23 Oct 2019 //
FDA
NCLT approves Dhanuka Lab’s Rs 1,116 crore plan to buy debt-hit Orchid Pharma
25 Jun 2019 //
ECONOMIC TIMES
Dhanuka Laboratories leads race for Orchid Pharma
07 Jun 2019 //
ECONOMIC TIMES
Orchid Pharma says closer to resolution as RP has received three plans
20 May 2019 //
BUSINESS-STANDARD
Orchid Pharma locked at upper circuit on USFDA nod
14 May 2019 //
MONEYCONTROL
Orchid Pharma faces liquidation as lenders reject resolution plan
14 May 2018 //
ECONOMIC TIMES
Orchid gets three final bids at par with liquidation value
19 Mar 2018 //
ECONOMIC TIMES
Aurobindo says reports inaccurate; Dr Reddy`s won`t comment on speculation
18 Dec 2017 //
IN PHARMATECHNOLOGIST
Serum Institute of India sells 7.50 lakh shares of Orchid Pharma
18 Dec 2017 //
MONEYCNTROL
Aurobindo, Dr. Reddy’s on report they`re in lead to buy Orchid
18 Dec 2017 //
FIERCE PHARMA
Lenders of Orchid Pharma appoint Sripatham Ramkumar as resolution professional
17 Nov 2017 //
ECONOMIC TIMES
Orchid Pharma gets EIR from USFDA for its Alathur facility
21 Sep 2017 //
ECONOMIC TIMES